Bilcare, a leading innovation-driven technology solution company, has been associated with Abbot, to provide secure, non-clonable ‘track and trace technology’ for protection of Abbott’s exports across globe. Bilcare will provide end-to-end holistic solutions to Abbott for track and trace and authentication as per global standards. Bilcare will also build the ability to scale the service requirements to accommodate future needs.
The association will bring multi-level benefits to Abbott including capability to deal with on-going changes in government mandates, reduced spend on IT assets and services, handle high volume (billions of records) serialised data and its retention and allowing the company to manage any country-specific additional data requirements.
Abbott is a key client as it helps reinforce Bilcare’s capabilities to provide value to the pharma industry. Bilcare is confident that the synergy will go a long way with the organisation providing best available solutions to Abbott. With well-equipped non-Clonable track and trace technology, the company ascertains that the protection of the export products meets the government standards for export.
Bilcare’s non-Clonable track and trace solution is secure, cost effective which facilitated Abbott to protect it exports brands and comply with Government’s DGFT mandate without hampering current productivity.
This technology provides ‘secure track and trace’ along with non-ClonableID making it impossible for counterfeiters to copy. Conventional track and trace solution provide traceability but cannot provide protection from counterfeit which is the key motive to implement the mandate.
Bilcare Technologies’ secure track and trace and authentication solution can authenticate combined with track and trace, manage billions of records of serialised data and retain as per GS1/EPCIS, standardise data exchange with port authorities and importers for international trade, and enable accountability along with integration and outcomes to all stakeholders.
EP News Bureau – Mumbai
- Advertisement -
